Skip to main content
Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
24.80
+0.37 (1.51%)
At close: Apr 28, 2026, 4:00 PM EDT
24.80
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Agios Pharmaceuticals Revenue

In the year 2025, Agios Pharmaceuticals had annual revenue of $54.03M with 48.03% growth. Agios Pharmaceuticals had revenue of $19.97M in the quarter ending December 31, 2025, with 86.09% growth.

Revenue (ttm)
$54.03M
Revenue Growth
+48.03%
P/S Ratio
26.79
Revenue / Employee
$100,052
Employees
540
Market Cap
1.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202554.03M17.53M48.03%
Dec 31, 202436.50M9.68M36.07%
Dec 31, 202326.82M12.58M88.36%
Dec 31, 202214.24M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ardelyx 407.32M
Immunocore Holdings 400.02M
Iovance Biotherapeutics 263.50M
Viridian Therapeutics 70.85M
Immatics 56.67M
Precigen 9.68M
Maze Therapeutics 2.50M
Revenue Rankings

AGIO News

More News